CYTOKINETICS INC (CYTK) Stock Earnings Estimates
NASDAQ:CYTK • US23282W6057
62.22 USD
-0.41 (-0.65%)
At close: Feb 27, 2026
62.22 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 94.6M 34.38% | 7.53M -92.04% | 18.474M 145.34% | 81.644M 341.94% | 121.08M 48.30% | 381.17M 214.81% | 915.13M 140.08% | 1.413B 54.40% | 2.179B 54.21% | 3.106B 42.54% | 3.926B 26.40% | 4.7B 19.71% | |
| EBITDA YoY % growth | -318.39M -73.02% | -484.313M -52.11% | -526.717M -8.76% | -616.078M -16.97% | -699.722M -13.58% | -479.173M 31.52% | -99.389M 79.26% | 575.11M 678.65% | 1.032B 79.44% | 1.154B 11.82% | 1.158B 0.35% | N/A | |
| EBIT YoY % growth | -324.2M -74.02% | -496.205M -53.06% | -536.248M -8.07% | -624.533M -16.46% | -721.032M -15.45% | -531.956M 26.22% | -92.201M 82.67% | 171.69M 286.21% | 723.17M 321.21% | 1.429B 97.60% | 2.088B 46.12% | 2.723B 30.41% | |
| Operating Margin | -342.71% | -6,589.71% | -2,902.72% | -764.95% | -595.50% | -139.56% | -10.08% | 12.15% | 33.19% | 46.01% | 53.18% | 57.94% | |
| EPS YoY % growth | -4.22 -49.12% | -5.45 -29.15% | -5.26 3.49% | -6.48 -24.71% | -6.18 5.82% | -4.48 27.53% | -1.75 60.91% | 1.94 211.11% | 6.53 235.66% | 11.88 82.03% | 16.89 42.17% | 20.82 23.24% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.66 -19.36% | -1.64 -46.56% | -1.59 37.71% | -1.50 -0.15% | -0.98 40.98% | -0.90 45.32% | -0.71 55.05% | 0.09 106.11% |
| Revenue Q2Q % growth | 10.821M 585.31% | 22.211M -66.73% | 33.559M 1,633.42% | 83.191M 368.42% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -188.505M -22.94% | -182.575M -70.76% | -177.317M -11.18% | -120.768M 31.89% | -120.401M 36.13% | -109.65M 39.94% | -98.93M 44.21% | 13.413M 111.11% |
| EBIT Q2Q % growth | -188.54M -21.15% | -185.767M -66.60% | -182.799M -9.62% | -163.937M 8.97% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -1.50 -19.05% | -1.49 | -0.01 | -0.97% |
| Q3 2025 Q2Q % growth | -2.55 -87.50% | -1.61 | -0.94 | -58.24% |
| Q2 2025 Q2Q % growth | -1.12 14.50% | -1.40 | 0.28 | 20.28% |
| Q1 2025 Q2Q % growth | -1.39 -4.51% | -1.41 | 0.02 | 1.37% |
| Q4 2024 Q2Q % growth | -1.26 8.70% | -1.22 | -0.04 | -3.56% |
| Q3 2024 Q2Q % growth | -1.36 -0.74% | -1.27 | -0.09 | -6.82% |
| Q2 2024 Q2Q % growth | -1.31 2.24% | -1.08 | -0.23 | -21.59% |
| Q1 2024 Q2Q % growth | -1.33 3.62% | -1.16 | -0.17 | -14.19% |
| Q4 2023 Q2Q % growth | -1.38 4.83% | -0.99 | -0.39 | -39.39% |
| Q3 2023 Q2Q % growth | -1.35 11.18% | -0.76 | -0.59 | -78.29% |
| Q2 2023 Q2Q % growth | -1.34 -482.61% | -1.17 | -0.17 | -14.64% |
| Q1 2023 Q2Q % growth | -1.38 -35.29% | -1.22 | -0.16 | -12.82% |
| Q4 2022 Q2Q % growth | -1.45 -302.78% | -1.23 | -0.22 | -17.89% |
| Q3 2022 Q2Q % growth | -1.52 -60.00% | -1.19 | -0.33 | -27.35% |
| Q2 2022 Q2Q % growth | -0.23 73.26% | -1.04 | 0.81 | 77.91% |
| Q1 2022 Q2Q % growth | -1.02 -54.55% | -0.96 | -0.06 | -5.96% |
| Q4 2021 Q2Q % growth | -0.36 41.94% | -0.86 | 0.50 | 57.99% |
| Q3 2021 Q2Q % growth | -0.95 -1,800.00% | -0.79 | -0.16 | -20.57% |
| Q2 2021 Q2Q % growth | -0.86 -26.47% | -0.67 | -0.19 | -27.75% |
| Q1 2021 Q2Q % growth | -0.66 | -0.60 | -0.06 | -10.85% |
| Q4 2020 Q2Q % growth | -0.62 | -0.31 | -0.31 | -101.77% |
| Q3 2020 Q2Q % growth | -0.05 | -0.34 | 0.29 | 85.48% |
| Q2 2020 Q2Q % growth | -0.68 | -0.58 | -0.10 | -17.25% |
| Q1 2020 Q2Q % growth | -0.66 | -0.51 | -0.15 | -29.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 17.76M 4.92% | 7.049M | 10.711M | 151.95% |
| Q3 2025 Q2Q % growth | 1.936M 318.14% | 3.627M | -1.691M | -46.62% |
| Q2 2025 Q2Q % growth | 66.769M 26,714.86% | 2.431M | 64.338M | 2,646.57% |
| Q1 2025 Q2Q % growth | 1.579M 89.10% | 1.227M | 352K | 28.69% |
| Q4 2024 Q2Q % growth | 16.927M 912.38% | 1.776M | 15.151M | 853.10% |
| Q3 2024 Q2Q % growth | 463K 22.49% | 1.219M | -756K | -62.02% |
| Q2 2024 Q2Q % growth | 249K -71.28% | 940.012K | -691.012K | -73.51% |
| Q1 2024 Q2Q % growth | 835K -81.90% | 917.612K | -82.612K | -9.00% |
| Q4 2023 Q2Q % growth | 1.672M -14.69% | 10.985M | -9.313M | -84.78% |
| Q3 2023 Q2Q % growth | 378K -85.00% | 20.649M | -20.271M | -98.17% |
| Q2 2023 Q2Q % growth | 867K -99.03% | 5.92M | -5.053M | -85.35% |
| Q1 2023 Q2Q % growth | 4.613M 301.13% | 2.131M | 2.482M | 116.47% |
| Q4 2022 Q2Q % growth | 1.96M -96.47% | 7.241M | -5.281M | -72.93% |
| Q3 2022 Q2Q % growth | 2.52M -53.68% | 3.017M | -497K | -16.47% |
| Q2 2022 Q2Q % growth | 88.97M 3,032.75% | 3.704M | 85.266M | 2,302.00% |
| Q1 2022 Q2Q % growth | 1.15M -82.44% | 4.924M | -3.774M | -76.65% |
| Q4 2021 Q2Q % growth | 55.6M 727.38% | 6.321M | 49.279M | 779.61% |
| Q3 2021 Q2Q % growth | 5.44M -86.95% | 6.465M | -1.025M | -15.85% |
| Q2 2021 Q2Q % growth | 2.84M -20.89% | 5.559M | -2.719M | -48.91% |
| Q1 2021 Q2Q % growth | 6.55M 71.02% | 6.715M | -165K | -2.46% |
| Q4 2020 Q2Q % growth | 6.72M | 8.729M | -2.009M | -23.02% |
| Q3 2020 Q2Q % growth | 41.69M | 4.097M | 37.593M | 917.57% |
| Q2 2020 Q2Q % growth | 3.59M | 4.154M | -564K | -13.58% |
| Q1 2020 Q2Q % growth | 3.83M | 5.106M | -1.276M | -24.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.23% | 0.59% | -13.09% |
| Revenue | -0.24% | -34.76% | 0% | -4.67% |